CNC240705C71000
- 0.25
- 0.000.00%
Centene Newsroom
Medicare Advantage Linked to Fattest Gross Profits in Insurance: Report
CENTENE CORPORATION TO HOST 2024 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL
ST. LOUIS, July 2, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024
Sunflower Health Plan and Centene Foundation Announce $200,000 Grant to GoodLife Innovations
Partnership to Improve Behavioral Health Support for Kansans with Intellectual and Developmental DisabilitiesLENEXA, Kan., July 1, 2024 /PRNewswire/ -- Sunflower Health Plan ("Sunflower"), a managed c
Centene (NYSE:CNC) Hasn't Managed To Accelerate Its Returns
Barclays Maintains Centene(CNC.US) With Buy Rating, Cuts Target Price to $90
Barclays analyst Andrew Mok CFA maintains $Centene(CNC.US)$ with a buy rating, and adjusts the target price from $104 to $90.According to TipRanks data, the analyst has a success rate of 46.1% and a t
How Is Centene's Stock Performance Compared to Other Healthcare Stocks?
Barclays Adjusts Price Target on Centene to $90 From $104, Maintains Overweight Rating
Centene (CNC) has an average outperform rating and a price target range of $76 to $110, according to analysts polled by Capital IQ.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Here's Why We Think Centene (NYSE:CNC) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But the reality is that when a company lose
How Is The Market Feeling About Centene?
Centene's (NYSE:CNC) short percent of float has risen 37.81% since its last report. The company recently reported that it has 13.05 million shares sold short, which is 2.77% of all regular shares that
Goldman's Top 50 High Sharpe Ratio Stocks
Goldman Sachs analysts rebalanced their “high Sharpe Ratio” basket, which identifies 50 S&P 500 (SP500) stocks with the highest prospective risk-adjusted returns compared to their sector peers.
Centene Price Target Maintained With a $110.00/Share by Oppenheimer
Centene Price Target Maintained With a $110.00/Share by Oppenheimer
Navigating 11 Analyst Ratings For Centene
During the last three months, 11 analysts shared their evaluations of Centene (NYSE:CNC), revealing diverse outlooks from bullish to bearish.In the table below, you'll find a summary of their recent r
Oppenheimer Reiterates Outperform on Centene, Maintains $110 Price Target
Oppenheimer analyst Michael Wiederhorn reiterates Centene (NYSE:CNC) with a Outperform and maintains $110 price target.
Oppenheimer Maintains Centene(CNC.US) With Buy Rating, Maintains Target Price $110
Oppenheimer analyst Michael Wiederhorn maintains $Centene(CNC.US)$ with a buy rating, and maintains the target price at $110.According to TipRanks data, the analyst has a success rate of 66.9% and a t
Why Centene (CNC) Is a Top Value Stock for the Long-Term
Here's How Much You Would Have Made Owning Centene Stock In The Last 10 Years
Centene (NYSE:CNC) has outperformed the market over the past 10 years by 3.2% on an annualized basis producing an average annual return of 13.99%. Currently, Centene has a market capitalization of $36
Federal Government to Revise Medicare Advantage Plans Ratings
Cantor Fitzgerald Maintains Centene(CNC.US) With Buy Rating, Maintains Target Price $90
Cantor Fitzgerald analyst Sarah James maintains $Centene(CNC.US)$ with a buy rating, and maintains the target price at $90.According to TipRanks data, the analyst has a success rate of 63.0% and a tot
Centene Price Target Maintained With a $90.00/Share by Cantor Fitzgerald
Centene Price Target Maintained With a $90.00/Share by Cantor Fitzgerald